JPRN-UMIN000043201已完成未知
Population Pharmacokinetics and Evaluation dosing of Ceftolozane-Tazobactam in Critically ill Patients - Population Pharmacokinetics and Evaluation dosing of Ceftolozane-Tazobactam in Critically ill Patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with a history of anaphylaxis-like symptoms due to ceftolozan tazobactam 2) Patients diagnosed as pregnant at the time of consent 3) Patients who participate in or participate in other evaluations
研究者
相似试验
尚未招募
3 期
Determination of Correct hydroxyurea dose in Dickle Cell Anemia PatientsCTRI/2020/08/027022ICMR New Delhi
招募中
不适用
Population pharmacokinetic and pharmacodynamic modeling of propofol in underweight patients under general anesthesiaKCT0001760Asan Medical Center20
进行中（未招募）
不适用
Population pharmacokinetic and pharmacodynamic modeling of gabapentin in neuropathic pain - Effect of adjuvant pharmacotherapyEUCTR2009-010783-41-SEppsala University
已完成
不适用
Population Pharmacokinetic and Pharmacodynamic Modeling of Freefol-MCT® in Healthy VolunteersKCT0001931Asan Medical Center60
进行中（未招募）
1 期
ow dose tranexamic acid for craniosynostosis surgeryEUCTR2013-001056-35-ITIRCCS Istituto Giannina Gaslini60